RNA vaccine, conceptual illustration. Close-up of a molecule of RNA (ribonucleic acid, blue) being injected into a patient. The first RNA vaccine approved for human use, developed against the SARS-CoV-2 coronavirus by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG32175228
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
artwork2019-cov2019-ncovartworkbiologicalbiologyconceptsconceptualconditioncoronaviruscovid-19diseasedisorderepidemichcovhumanbodyillustrationimmunisationimmunisingimmunityimmunizinginjectinginjectionno-onenobodypandemicsars-covsars-cov-2vaccinatingvaccinationvaccineviralrnamessengerrnamrnaribonucleicacidbnt162b2pfizerbiontechfirstbiotechnologybiotechnological1st
1st2019-cov2019-ncovacidartworkartworkbiologicalbiologybiontechbiotechnologicalbiotechnologybnt162b2bodyconceptsconceptualconditioncoronaviruscovid-19diseasedisorderepidemicfirsthcovhumanillustrationimmunisationimmunisingimmunityimmunizinginjectinginjectionmessengermrnano-onenobodypandemicpfizerribonucleicrnarnasars-covsars-cov-2vaccinatingvaccinationvaccineviral